The effects of anti-diabetic drugs on LDL subclasses: Any role for colesevelam? Editorial to: "Effect of colesevelam HCl monotherapy on lipid particles in type 2 diabetes mellitus" by R.S. Rosenson et al.

Manfredi Rizzo, Dimitri P. Mikhailidis, Khalid Al-Rasadi

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)205-207
Number of pages3
JournalCardiovascular Drugs and Therapy
Volume28
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Allylamine
Anticholesteremic Agents
Type 2 Diabetes Mellitus
Lipoproteins
Lipids
Pharmaceutical Preparations
Colesevelam Hydrochloride
oxidized low density lipoprotein

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine
  • Pharmacology
  • Medicine(all)

Cite this

@article{dd0dd7cf3eb746b4867bebea324fa674,
title = "The effects of anti-diabetic drugs on LDL subclasses: Any role for colesevelam? Editorial to: {"}Effect of colesevelam HCl monotherapy on lipid particles in type 2 diabetes mellitus{"} by R.S. Rosenson et al.",
author = "Manfredi Rizzo and Mikhailidis, {Dimitri P.} and Khalid Al-Rasadi",
year = "2014",
doi = "10.1007/s10557-014-6521-1",
language = "English",
volume = "28",
pages = "205--207",
journal = "Cardiovascular Drugs and Therapy",
issn = "0920-3206",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - The effects of anti-diabetic drugs on LDL subclasses

T2 - Any role for colesevelam? Editorial to: "Effect of colesevelam HCl monotherapy on lipid particles in type 2 diabetes mellitus" by R.S. Rosenson et al.

AU - Rizzo, Manfredi

AU - Mikhailidis, Dimitri P.

AU - Al-Rasadi, Khalid

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84903752630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903752630&partnerID=8YFLogxK

U2 - 10.1007/s10557-014-6521-1

DO - 10.1007/s10557-014-6521-1

M3 - Article

C2 - 24867816

AN - SCOPUS:84903752630

VL - 28

SP - 205

EP - 207

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 3

ER -